Patent application number | Description | Published |
20120288551 | Implantable Polymeric Device for Sustained Release of Sufentanil - Extended release of sufentanil is provided by implanting a device containing sufentanil into a mammal or human being. The device may include a solid biocompatible polymer matrix, and sufentanil may be encapsulated within the polymer matrix. The polymer matrix comprises a plurality of pores configured to allow contact between the sufentanil and a physiological fluid of a mammal into which the device is implanted to thereby release sufentanil in vivo from the device into the mammal. The devices may be used to treat opioid addiction or pain. | 11-15-2012 |
20130274282 | COMPOSITIONS AND METHODS COMPRISING CELECOXIB OR RELATED COMPOUNDS AND DEXTROMETHORPHAN - Pain and/or neurological disorders may be treated by administering a therapeutically effective amount of dextromethorphan and a therapeutically effective amount of a compound such as celecoxib that inhibits the metabolism of dextromethorphan, to a person in need thereof. The two compounds may be administered separately, or in a single dosage form or composition as described herein. | 10-17-2013 |
20130303485 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. Although an oral dosage form with enhanced bioavailability with respect to the bisphosphonate compound can be used, the treatment can also be effective using an oral dosage form that includes a bisphosphonate compound, such as zoledronic acid, wherein the bioavailability of the bisphosphonate is unenhanced, or is substantially unenhanced. | 11-14-2013 |
20130303486 | Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Pain Associated with Arthritis - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. Although an oral dosage form with enhanced bioavailability with respect to the bisphosphonate compound can be used, the treatment can also be effective using an oral dosage form that includes a bisphosphonate compound, such as zoledronic acid, wherein the bioavailability of the bisphosphonate is unenhanced, or is substantially unenhanced. | 11-14-2013 |
20130303487 | Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Inflammatory Pain and Related Conditions - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. Although an oral dosage form with enhanced bioavailability with respect to the bisphosphonate compound can be used, the treatment can also be effective using an oral dosage form that includes a bisphosphonate compound, such as zoledronic acid, wherein the bioavailability of the bisphosphonate is unenhanced, or is substantially unenhanced. | 11-14-2013 |
20130303488 | Compositions Comprising Zoledronic Acid or Related Compounds for Treatment of Complex Regional Pain Syndrome - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. Although an oral dosage form with enhanced bioavailability with respect to the bisphosphonate compound can be used, the treatment can also be effective using an oral dosage form that includes a bisphosphonate compound, such as zoledronic acid, wherein the bioavailability of the bisphosphonate is unenhanced, or is substantially unenhanced. | 11-14-2013 |
20140051669 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 02-20-2014 |
20140051718 | Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan - Neurological disorders may be treated by administering a therapeutically effective amount of dextromethorphan and a therapeutically effective amount of a compound such as celecoxib that inhibits the metabolism of dextromethorphan, to a person in need thereof. The two compounds may be administered separately, or in a single dosage form or composition as described herein. | 02-20-2014 |
20140107345 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 04-17-2014 |
20140249107 | DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249108 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING MUSCULOSKELETAL PAIN - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249109 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING ANKYLOSING SPONDYLITIS - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249110 | TREATMENT OF ARTHRITIS USING DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249111 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING MULTIPLE MYELOMA - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249112 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249113 | COMPOSITIONS FOR ORAL ADMINSTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING PAGET'S DISEASE OF BONE - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140249317 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-04-2014 |
20140256683 | TREATING DISEASE USING COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 09-11-2014 |
20140329773 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 11-06-2014 |
20140348916 | Treatment of Pain with Oral Dosage Forms Comprising Zoledronic Acid and An Enhancer - Disclosed herein are methods of treating or preventing pain. Typically, a pharmaceutical composition having a therapeutically effective amount of the zoledronic acid is administered to a mammal suffering from pain. The pharmaceutical composition may further comprise an enhancer, which can be a medium chain fatty acid salt, an ester, an ether, or a derivative of a medium chain fatty acid and can have a carbon chain length of from about 4 to about 20 carbon atoms. | 11-27-2014 |
20140349974 | ZOLEDRONIC ACID DOSAGE FORMS FOR THE TREATMENT OF PAIN - Treatment of pain and related conditions with oral dosage forms of zoledronic acid is described herein. | 11-27-2014 |
20150051175 | Co-Administration of Steroids and Zoledronic Acid to Prevent and Treat Pain - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 02-19-2015 |
20150057250 | INHIBITORS OF OSTEOCLAST ACTIVITY FOR TREATING ARTHRITIS - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 02-26-2015 |
Patent application number | Description | Published |
20130175826 | CHASSIS WITH RAISING BOX STRUCTURE TO ANCHOR PASSENGER SEATS - A motor vehicle chassis including a rear central cross member, a hollow beam positioned over the rear central cross member along this rear central cross member, and a floor seat-cushion support part including rear seat fittings, supported at the rear by the hollow beam positioned under the seat-cushion support part. The beam includes a rear raiser including a horizontal plate fixed to the rear central cross member and further includes a blanking sheet fixed to the horizontal plate of the rear raiser and including at least one anchoring reinforcement assembled on the inside of the hollow beam. The reinforcement, which forms a hollow box section, connects the rear raiser and the blanking sheet, an upper face of the anchoring reinforcement supports a connecting piece, the connecting piece also being assembled, on the outside of the hollow beam, with the rear raiser. | 07-11-2013 |
20130181483 | MOTOR VEHICLE CHASSIS WITH LATERAL SEAT-CUSHION SUPPORT REINFORCEMENT - A motor vehicle chassis includes two lateral floor supports and a seat-cushion support part positioned between two lateral raisers fixed on top of the lateral floor supports and assembled with the lateral floor supports. The chassis further includes two seat-cushion support reinforcements each assembled with a lateral floor support and with a lateral raiser, each seat-cushion support reinforcement including: a substantially horizontal plate extending the seat-cushion support part laterally, assembled with the lateral raiser along a substantially vertical mating edge of the plate, and a single support leg extending downwards from the plate, assembled with the lateral floor support, and the assembly end of which is positioned vertically below the plate, some distance from a projection onto the horizontal of the mating edge. | 07-18-2013 |
20130181486 | CHASSIS WITH RAISED REAR FLOOR AND METHOD OF ASSEMBLY - A motor vehicle chassis includes two side rail members covered at the front by two lateral floor reinforcements, a rear central cross member and a transverse reinforcement which is welded to the two lateral floor reinforcements, and a floor having a seat-cushion support part. The chassis further includes a rear raiser welded to the rear central cross member and two lateral raisers welded respectively to each of the two lateral floor reinforcements. The seat-cushion support part of the floor is welded to the two lateral raisers, to the rear raiser and to the transverse reinforcement, so as to create a space for an energy reservoir under the seat-cushion support part of the floor. | 07-18-2013 |
20130187371 | MOTOR VEHICLE CHASSIS HAVING A PART FOR ATTACHING BODYWORK ELEMENTS AND ELECTRICAL CABLES TO THE CENTRAL FLOOR - A motor vehicle chassis including two side skirt lateral flanks comprising a horizontal portion. The motor vehicle chassis also includes a central floor situated between the two side skirt lateral flanks and including a horizontal main surface and horizontal secondary surfaces for attachment to the horizontal portion of the lateral flanks. The horizontal surfaces exhibit a height difference. The motor vehicle chassis also includes at least one fixing piece on each side of the central floor, between the horizontal main surface of the central floor and one of the side skirt lateral flanks. The at least one fixing piece includes two horizontal parts for fixing to the central floor, which are respectively fixed to the horizontal main surface and to a horizontal lateral surface of the central floor. One of the horizontal parts includes a first passage to accept a fixing lug of a bodywork element. | 07-25-2013 |